Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Salivary Gland Neoplasms 1Rectal Neoplasms 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neoplasms 1Metastatic Malignant Female Reproductive System Neoplasm 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Breast Carcinoma In Situ 1Brain Neoplasms 1Astrocytoma 1Anatomic Stage II Breast Cancer AJCC v8 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Magnetic Resonance Spectroscopy 6X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 4Cisplatin 4Biopsy 4selpercatinib 3larotrectinib 3Vincristine 3Carboplatin 3erdafitinib 2ensartinib 2Temozolomide 2Radiotherapy 2Methotrexate 2Cyclophosphamide 2Chemotherapy, Adjuvant 2ulixertinib 1tipifarnib 1tazemetostat 1palbociclib 1olaparib 1niraparib 1neratinib 1lenvatinib 1ivosidenib 1ibrutinib 1entrectinib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Central Nervous System Neoplasms × Radiotherapy, Conformal × Clear all
NCT00978458 2025-09-08

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
540 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡